Korsana Biosciences, Inc. (KRSA): Total Assets
$9.98M
As of 2025-12-31
$6.93M
As of 2026-06-30
-18.0%
3-year compound annual growth
-38.7%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.98M | +4.3% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $9.57M | -28.4% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $13.37M | -26.0% | 2025-11-12, Balance as of period end |
| 2022-12-31 | $18.08M | -69.5% | 2024-03-05, Balance as of period end |
| 2021-12-31 | $59.33M | -48.6% | 2023-03-22, Balance as of period end |
| 2020-12-31 | $115.38M | -38.1% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $186.48M | n/m | 2021-02-25, Balance as of period end |
| 2018-12-31 | $7.40M | n/a | 2020-03-12, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $9.98M | +4.3% |
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | $530.92M | +42.0% |
| Lipocine Inc. (LPCN) | 2025-12-31 | $17.01M | -24.5% |
| Bio Essence Corp (BIOE) | 2025-12-31 | $422.5K | +50.3% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $6.34M | -22.2% |
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | $58.62M | +60.0% |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | $296.41M | -31.9% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $353.77M | -26.6% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $8.36M | +21.2% |
Compare KRSA, DNTH, LPCN, BIOE side by side · Screen every company in Pharmaceutical Preparations ↗